Providing Consultative DMPK Solutions Bridging Drug Discovery and Development
21 Nov 2013

XenoTech and XenoGesis work together to facilitate outsourced drug metabolism and pharmacokinetics (DMPK) studies from early stage drug discovery through development and beyond. The partnership was developed to help mitigate the risk and cost associated with clinical failure. Efficacy and safety are now the leading causes of attrition and are linked to drug exposure in target and off-target tissues. While pharmacokinetics is no longer the leading cause of failure, a drug’s exposure is driven by its pharmacokinetic properties and ultimately remains critical for successful pharmacodynamics and safety. This webinar will showcase the consultative basis of the DMPK CRO alliance and highlight the capabilities with real-life examples of our unique combination of expertise.

Xenotech LLC



Show    per page
1 of 10 Page     1 2 3  ... Next 
Simultaneous Quantitative Determination and Screening of Pesticides in Fruits and Vegetables using LC-Q-Orbitrap-MS10 Dec 2014Read
Nanoparticle size characterization: Tips and Tricks8 Dec 2014Read
Sprint Bioscience on label-free fragment screening8 Dec 2014Read
Imaging Masterclass 3: Static vs. Dynamic Image Analysis8 Dec 2014Read
Laser Diffraction Masterclass 58 Dec 2014Read
How to characterize and optimize inkjet inks Part 38 Dec 2014Read
Exploring OMICS in 3D Microtissues4 Dec 2014Read
Trouble Free HPLC Analysis of Creams and Lotions: Beautiful Separations of Beauty Products2 Dec 2014Read
Advanced GPC Technology as a Part of Solving Complex Polymer Problems25 Nov 2014Read
Issues of Color in Histology in Medicine20 Nov 2014Read